Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents-Reference-Cited by-同舟云学术

Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents

Published:2013-09-30 Issue:19 Volume:56 Page:7651-7668
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Choi Jun Yong¹²,Calvet Claudia M.¹²,Gunatilleke Shamila S.¹²,Ruiz Claudia¹²,Cameron Michael D.¹²,McKerrow James H.¹²,Podust Larissa M.¹²,Roush William R.¹²

Affiliation:

1. Department of Chemistry and ∥Department of Molecular Therapeutics, Scripps Florida, Jupiter, Florida 33458, United States

2. Center for Discovery and Innovation in Parasitic Diseases and §Department of Pathology, University of California San Francisco, San Francisco, California 94158, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm401067s

Reference42 articles.

1. Antitrypanosomal Therapy for Chronic Chagas' Disease

2. Trypanosoma cruzi and Chagas' Disease in the United States

3. Chagas disease

4. Coronary Microvascular Disease in Chronic Chagas Cardiomyopathy Including an Overview on History, Pathology, and Other Proposed Pathogenic Mechanisms

5. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitors;Bioorganic & Medicinal Chemistry;2024-09

2. Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases;Future Medicinal Chemistry;2024-06-10

3. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents;European Journal of Medicinal Chemistry;2024-01

4. Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?;Medicinal Research Reviews;2023-12-24

5. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors;Scientific Reports;2023-11-29